M. Mahowald, S. Larney, N. Zaller, N. Scharff, L. Taylor, C. Beckwith, A. Noska, J. Rich, T. Flanigan
{"title":"2004年至2012年宾夕法尼亚州立监狱在押人员丙型肝炎感染负担特征分析","authors":"M. Mahowald, S. Larney, N. Zaller, N. Scharff, L. Taylor, C. Beckwith, A. Noska, J. Rich, T. Flanigan","doi":"10.1177/1078345815618384","DOIUrl":null,"url":null,"abstract":"Although hepatitis C (HCV) infection is common among prisoners, relatively few undergo evaluation for treatment. This study reports the prevalence of chronic infection and the genotype distribution among an incarcerated population. HCV antibody testing was provided to adults entering Pennsylvania prisons; confirmatory and genotype testing were offered to those eligible for treatment. Antibody prevalence among 101,727 individuals was 18.1%. Among 7,633 individuals who underwent confirmatory testing, 69.3% had detectable RNA. Among 3,247 individuals who underwent genotype testing, genotype 1 was the most common (76.6%). The rate of chronic infection after HCV exposure is similar to that reported in the community, as is genotype distribution. Correctional facilities provide access to a population with a high disease burden, creating a public health opportunity for evaluation and treatment.","PeriodicalId":15399,"journal":{"name":"Journal of Correctional Health Care","volume":"22 1","pages":"41 - 45"},"PeriodicalIF":0.8000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1078345815618384","citationCount":"10","resultStr":"{\"title\":\"Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012\",\"authors\":\"M. Mahowald, S. Larney, N. Zaller, N. Scharff, L. Taylor, C. Beckwith, A. Noska, J. Rich, T. Flanigan\",\"doi\":\"10.1177/1078345815618384\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although hepatitis C (HCV) infection is common among prisoners, relatively few undergo evaluation for treatment. This study reports the prevalence of chronic infection and the genotype distribution among an incarcerated population. HCV antibody testing was provided to adults entering Pennsylvania prisons; confirmatory and genotype testing were offered to those eligible for treatment. Antibody prevalence among 101,727 individuals was 18.1%. Among 7,633 individuals who underwent confirmatory testing, 69.3% had detectable RNA. Among 3,247 individuals who underwent genotype testing, genotype 1 was the most common (76.6%). The rate of chronic infection after HCV exposure is similar to that reported in the community, as is genotype distribution. Correctional facilities provide access to a population with a high disease burden, creating a public health opportunity for evaluation and treatment.\",\"PeriodicalId\":15399,\"journal\":{\"name\":\"Journal of Correctional Health Care\",\"volume\":\"22 1\",\"pages\":\"41 - 45\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/1078345815618384\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Correctional Health Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/1078345815618384\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Correctional Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1078345815618384","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012
Although hepatitis C (HCV) infection is common among prisoners, relatively few undergo evaluation for treatment. This study reports the prevalence of chronic infection and the genotype distribution among an incarcerated population. HCV antibody testing was provided to adults entering Pennsylvania prisons; confirmatory and genotype testing were offered to those eligible for treatment. Antibody prevalence among 101,727 individuals was 18.1%. Among 7,633 individuals who underwent confirmatory testing, 69.3% had detectable RNA. Among 3,247 individuals who underwent genotype testing, genotype 1 was the most common (76.6%). The rate of chronic infection after HCV exposure is similar to that reported in the community, as is genotype distribution. Correctional facilities provide access to a population with a high disease burden, creating a public health opportunity for evaluation and treatment.
期刊介绍:
The Journal of Correctional Health Care is the only national, peer-reviewed scientific journal to focus on this complex and evolving field. Targeting clinicians, allied health practitioners and administrators, it is the primary resource for information on research and developments in clinical care for chronic and infectious disease, mental health care, substance abuse treatment, health services management, quality improvement, medical records, medical-legal issues, discharge planning, staffing, cost analysis and other topics. Coverage includes empirical research, case studies, best practices, literature reviews and letters, plus NCCHC clinical guidelines and position statements. A self-study exam offers CE credit for health care professionals.